YV6-15201-41125 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-08
Dose 1 — Pfizer-BioNTech
2021-05-10
Registered in v-safe
2021-05-10
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Vision blurred — Feeling: Good · Site: Pain · Be unable to do your normal daily activities

Free text: On May 9 I experienced very blurry vision in my right eye and dizziness all day. By morning my vision returned to normal.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Survey response — day 7, dose 1
MedDRA: Blindness, Emergency care, Transient ischaemic attack, Unevaluable event, Vertigo — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Systemic reaction (other): May 9 I experienced VERTIGO and partial VISION LOSS. Admitted thru ER for 2 days of cardio neuro testing at local hospital. Was told I had a TIA or mini stroke. · Healthcare visit (other): Extensive tests to include CAT Scan, EKG, Echocardiogram, MRI and blood work

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Report sent to call center — day 7, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-12
Survey response — day 35, dose 1
MedDRA: Abdominal pain, Back pain, Blood urine present, Fatigue, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Blood in urineAbdominal painFatigueBack pain · Healthcare visit (other): CT scan and Urine Test

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-12
Report sent to call center — day 35, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-22
Call 1 — Could Not Reach Participant
2021-06-25
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-05-19	Unsuccessful
2021-06-12	Unsuccessful

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-10

Systemic reaction (other): On May 9 I experienced very blurry vision in my right eye and dizziness all day. By morning my vision returned to normal.

Release 8 — day 7, dose 1

2021-05-19

Systemic reaction (other): May 9 I experienced VERTIGO and partial VISION LOSS. Admitted thru ER for 2 days of cardio neuro testing at local hospital. Was told I had a TIA or mini stroke.

Healthcare visit (other): Extensive tests to include CAT Scan, EKG, Echocardiogram, MRI and blood work

Release 9 — day 35, dose 1

2021-06-12

Symptoms: Blood in urineAbdominal painFatigueBack pain

Healthcare visit (other): CT scan and Urine Test

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Abdominal pain	✓	✓	✓
SD	Back pain	✓	✓	✓
SD	Blood urine present	✓	✓	✓
SD	Fatigue	✓	✓	✓
SRO	Blindness	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Emergency care	✓	✓	✓
SRO	Transient ischaemic attack	✓	✓	✓
SRO	Vertigo	✓	✓	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release